To include your compound in the COVID-19 Resource Center, submit it here.

NBI-34060 immediate-release: Phase II results; Phase III

In a double-blind Phase II trial of NBI-34060-IR in 42 elderly patients with primary

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE